The Maryland Tech Council (MTC) concluded its Bio+Tech18 Conference yesterday in Baltimore with the announcement of Remedy Plan Therapeutics as the winner of its Inaugural Start-Up Pitch Contest. Remedy Plan Therapeutics is a biotechnology company developing drugs that target cancer stem cells to inhibit tumor growth and proliferation.
{iframe}https://www.businesswire.com/news/home/20180921005335/en/Remedy-Plan-Therapeutics-Named-Winner-MTC%E2%80%99s-Inaugural{/iframe}